Literature DB >> 23082855

Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics.

Bhavinkumar B Patel1, Carlos A Barrero, Alan Braverman, Phillip D Kim, Kelly A Jones, Dian Er Chen, Russell P Bowler, Salim Merali, Steven G Kelsen, Anthony T Yeung.   

Abstract

Immunodepletion of abundant plasma proteins increases the depth of proteome penetration by mass spectrometry. However, the nature and extent of immunodepletion and the effect of off-target depletion on the quantitative comparison of the residual proteins have not been critically addressed. We performed mass spectrometry label-free quantitation to determine which proteins were immunodepleted and by how much. Two immunodepletion resins were compared: Qproteome (Qiagen) which removes albumin+immunoglobulins and Seppro IgY14+SuperMix (Sigma-Aldrich) which removes 14 target proteins plus a number of unidentified proteins. Plasma collected by P100 proteomic plasma collection tubes (BD) from 20 human subjects was individually immunodepleted to minimize potential variability, prior to pooling. The abundant proteins were quantified better when using only albumin+immunoglobulins removal (Qproteome), while lower abundance proteins were evaluated better using exhaustive immunodepletion (Seppro IgY14+SuperMix). The latter resin removed at least 155 proteins, 38% of the plasma proteome in protein number and 94% of plasma protein in mass. The depth of immunodepletion likely accounts for the effectiveness of this resin in revealing low abundance proteins. However, the more profound immunodepletion achieved with the IgY14+SuperMix may lead to false-positive fold-changes between comparison groups if the reproducibility and efficiency of the depletion of a given protein are not considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23082855      PMCID: PMC3518753          DOI: 10.1021/pr300686k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  28 in total

1.  Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.

Authors:  Peter Juhasz; Moira Lynch; Mahadevan Sethuraman; Jennifer Campbell; Wade Hines; Manuel Paniagua; Leijun Song; Mahesh Kulkarni; Aram Adourian; Yu Guo; Xiaohong Li; Stephen Martin; Neal Gordon
Journal:  J Proteome Res       Date:  2010-11-02       Impact factor: 4.466

2.  Immunodepletion of albumin from human serum samples.

Authors:  A Burgess-Cassler; J J Johansen; N Kendrick
Journal:  Clin Chim Acta       Date:  1989-08-31       Impact factor: 3.786

3.  Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein.

Authors:  Yasushi Ishihama; Yoshiya Oda; Tsuyoshi Tabata; Toshitaka Sato; Takeshi Nagasu; Juri Rappsilber; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2005-06-14       Impact factor: 5.911

4.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

5.  Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms.

Authors:  Hanna Eriksson; Johan Lengqvist; Joel Hedlund; Kristina Uhlén; Lukas M Orre; Bengt Bjellqvist; Bengt Persson; Janne Lehtiö; Per-Johan Jakobsson
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

6.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

7.  Assessment of an ad hoc procedure for isolation and characterization of human albuminome.

Authors:  Domenica Scumaci; Marco Gaspari; Milena Saccomanno; Giuseppe Argirò; Barbara Quaresima; Concetta M Faniello; Pietrantonio Ricci; Francesco Costanzo; Giovanni Cuda
Journal:  Anal Biochem       Date:  2011-06-30       Impact factor: 3.365

8.  Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry.

Authors:  Giuseppina Maccarrone; Dale Milfay; Isabel Birg; Marcus Rosenhagen; Florian Holsboer; Rudolf Grimm; Jerome Bailey; Nina Zolotarjova; Christoph W Turck
Journal:  Electrophoresis       Date:  2004-07       Impact factor: 3.535

9.  Proteomic analyses of pancreatic cyst fluids.

Authors:  Eileen Ke; Bhavinkumar B Patel; Tiffany Liu; Xin-Ming Li; Oleh Haluszka; John P Hoffman; Hormoz Ehya; Nancy A Young; James C Watson; David S Weinberg; Minhhuyen T Nguyen; Steven J Cohen; Neal J Meropol; Samuel Litwin; Jeffrey L Tokar; Anthony T Yeung
Journal:  Pancreas       Date:  2009-03       Impact factor: 3.327

10.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

Authors:  Meilan K Han; Ella A Kazerooni; David A Lynch; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Gerard J Criner; Victor Kim; Russell P Bowler; Nicola A Hanania; Antonio R Anzueto; Barry J Make; John E Hokanson; James D Crapo; Edwin K Silverman; Fernando J Martinez; George R Washko
Journal:  Radiology       Date:  2011-07-25       Impact factor: 11.105

View more
  15 in total

1.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.

Authors:  Hasmik Keshishian; Michael W Burgess; Michael A Gillette; Philipp Mertins; Karl R Clauser; D R Mani; Eric W Kuhn; Laurie A Farrell; Robert E Gerszten; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2015-02-27       Impact factor: 5.911

2.  Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.

Authors:  Harvey E Johnston; Matthew J Carter; Kerry L Cox; Melanie Dunscombe; Antigoni Manousopoulou; Paul A Townsend; Spiros D Garbis; Mark S Cragg
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

3.  Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.

Authors:  Salim Merali; Carlos A Barrero; Russell P Bowler; Diane Er Chen; Gerard Criner; Alan Braverman; Samuel Litwin; Anthony Yeung; Steven G Kelsen
Journal:  COPD       Date:  2013-10-10       Impact factor: 2.409

Review 4.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

5.  Humanin Blocks the Aggregation of Amyloid-β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3.

Authors:  Deanna Price; Sadaf Dorandish; Asana Williams; Brandon Iwaniec; Alexis Stephens; Keyan Marshall; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Biochemistry       Date:  2020-05-20       Impact factor: 3.162

6.  Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers.

Authors:  Kelly A Jones; Phillip D Kim; Bhavinkumar B Patel; Steven G Kelsen; Alan Braverman; Derrick J Swinton; Philip R Gafken; Lisa A Jones; William S Lane; John M Neveu; Hon-Chiu E Leung; Scott A Shaffer; John D Leszyk; Bruce A Stanley; Todd E Fox; Anne Stanley; Michael J Hall; Heather Hampel; Christopher D South; Albert de la Chapelle; Randall W Burt; David A Jones; Levy Kopelovich; Anthony T Yeung
Journal:  J Proteome Res       Date:  2013-09-19       Impact factor: 4.466

Review 7.  Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.

Authors:  Chaochao Wu; Jicheng Duan; Tao Liu; Richard D Smith; Wei-Jun Qian
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-01-12       Impact factor: 3.205

8.  Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.

Authors:  Hasmik Keshishian; Michael W Burgess; Harrison Specht; Luke Wallace; Karl R Clauser; Michael A Gillette; Steven A Carr
Journal:  Nat Protoc       Date:  2017-07-27       Impact factor: 13.491

9.  Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

Authors:  Bryan Krastins; Amol Prakash; David A Sarracino; Dobrin Nedelkov; Eric E Niederkofler; Urban A Kiernan; Randall Nelson; Maryann S Vogelsang; Gouri Vadali; Alejandra Garces; Jennifer N Sutton; Scott Peterman; Gregory Byram; Bruno Darbouret; Joëlle R Pérusse; Nabil G Seidah; Benoit Coulombe; Johan Gobom; Erik Portelius; Josef Pannee; Kaj Blennow; Vathany Kulasingam; Lewis Couchman; Caje Moniz; Mary F Lopez
Journal:  Clin Biochem       Date:  2013-01-08       Impact factor: 3.281

10.  In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion.

Authors:  Lynn A Beer; Bonnie Ky; Kurt T Barnhart; David W Speicher
Journal:  Methods Mol Biol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.